Novo's Suit Over Prandin ANDA Survives Bid To Toss

Law360, New York (June 19, 2009, 12:00 AM EDT) -- A federal judge has tossed a bid from Caraco Pharmaceutical Laboratories Ltd. and its majority shareholder Sun Pharmaceutical Industries Ltd. to find a patent held by Novo Nordisk Inc. invalid in a dispute over Caraco's launch of a generic version of the diabetic drug Prandin.

Judge Avern Cohn denied Caraco's motion for summary judgment on invalidity on Thursday in the U.S. District Court for the Eastern District of Michigan. Reasons for Judge Cohn's ruling were not made public.

“I think it's fair to say that Judge...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.